This afternoon.
The US Food and Drug Administration (FDA) has authorised a booster dose for young children ages 5 to 11 years old.
Via FDA:
Today, we amended the emergency use authorisation (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 through 11 years of age at least five months after completion of a primary series with the Pfizer-BioNTech COVID-19 Vaccine.
“While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term effects, even following initially mild disease,” said FDA Commissioner Robert M. Califf, M.D.
“Vaccination continues to be the most effective way to prevent COVID-19 and its severe consequences, and it is safe.”
Shutterstock













